Cytosorbents Corporation

NasdaqCM:CTSO Stock Report

Market Cap: US$50.0m

Cytosorbents Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqCM:CTSO Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
13 Dec 24BuyUS$19,294Peter MarianiIndividual20,000US$0.96
12 Dec 24BuyUS$27,975Peter MarianiIndividual31,363US$0.89

Insider Trading Volume

Insider Buying: CTSO insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of CTSO?
Owner TypeNumber of SharesOwnership Percentage
Hedge Funds2,755,4275.04%
Individual Insiders5,945,79410.9%
Institutions15,189,17327.8%
General Public30,789,17556.3%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 4.7%.


Top Shareholders

Top 25 shareholders own 42.38% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
7.35%
Mary Ley
4,016,323US$3.7m0%no data
5.44%
Avenir Corporation
2,975,559US$2.7m0.18%0.26%
5.04%
Skylands Capital, LLC
2,755,427US$2.5m-3%0.34%
3.83%
Granahan Investment Management, LLC
2,094,882US$1.9m-21.4%0.07%
3.57%
The Vanguard Group, Inc.
1,949,551US$1.8m0%no data
3.26%
Neuberger Berman Investment Advisers LLC
1,781,360US$1.6m15.9%no data
2.97%
Sargent Investment Group, LLC
1,626,247US$1.5m13.5%0.25%
1.46%
CM Management, LLC
800,000US$732.0k-5.88%0.59%
1.35%
Phillip Chan
739,370US$676.5k0%no data
1.15%
BlackRock, Inc.
627,305US$574.0k-4.35%no data
1.11%
Medical Strategy GmbH, Asset Management Arm
606,984US$555.4k0%0.03%
0.99%
Jackson National Asset Management, LLC
541,568US$495.5k-35%0.01%
0.85%
Geode Capital Management, LLC
467,058US$427.4k7.46%no data
0.73%
Peter Mariani
401,363US$367.2k0%no data
0.65%
Victory Capital Management Inc.
357,974US$327.5k-20.2%no data
0.54%
Kathleen Bloch
294,941US$269.9k0%no data
0.51%
Vincent Capponi
281,134US$257.2k0%no data
0.32%
CIBC Private Wealth Advisors, Inc.
172,649US$158.0k0%no data
0.26%
State Street Global Advisors, Inc.
140,293US$128.4k0%no data
0.21%
Morgan Stanley, Investment Banking and Brokerage Investments
112,439US$102.9k0.26%no data
0.18%
Osaic Wealth, Inc. , Asset Management Arm
97,140US$88.9k11.5%no data
0.17%
Efthymios Deliargyris
93,959US$86.0k0%no data
0.15%
AMH Equity, Ltd.
82,800US$75.8k0%0.08%
0.15%
Renaissance Technologies LLC
79,620US$72.9k5.01%no data
0.14%
Northern Trust Global Investments
74,859US$68.5k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 20:57
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Cytosorbents Corporation is covered by 10 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Boran WangAegis Capital Corporation
Jonathan AschoffBrean Capital
Jason KolbertD. Boral Capital LLC.